Neuroendocrine Perspectives. Volume 3 [electronic resource] / edited by Eugenio E. Müller and Robert M. MacLeod.
Saved in:
| Online Access: |
Full Text (via ScienceDirect) |
|---|---|
| Other Authors: | , |
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Burlington :
Elsevier Science,
1984.
|
| Subjects: |
Table of Contents:
- Front Cover; Neuroendocrine Perspectives; Copyright Page; Introduction; Contributors; Table of Contents; Chapter 1. Topography of chemically identified neurons in the central nervous system: progress in 1981 -1983; INTRODUCTION; AMINO ACIDS; ACETYLCHOLINE; BIOGENIC AMINES; NEUROPEPTIDES; CONCLUSIONS; ACKNOWLEDGMENTS; REFERENCES; Chapter 2. Hypothalamic organization of corticotropin releasing factor (CRF) producing structures; INTRODUCTION; THE HYPOPHYSIOTROPIC NEURONS; LOCATION OF HYPOTHALAMIC CRF-PRODUCING STRUCTURES; THE ROLE OF THE HYPOTHALAMIC PARAVENTRICULAR NUCLEUS
- IS THE NEURAL LOBE INVOLVED IN THE CONTROL OF ACTH SECRETION?WHAT IS CRF?; THE 41-RESIDUE CRF (CRF-41); THE NEUROHYPOPHYSEAL PEPTIDES VASOPRESSIN AND OXYTOCIN; ANGIOTENSIN II; EPINEPHRINE AND NOREPINEPHRINE; OTHER SUBSTANCES WITH CRF ACTIVITY; PERSPECTIVES OF CRF; REFERENCES; Chapter 3. Neuropeptides in the cerebrospinal fluid; INTRODUCTION; HYPOPHYSIOTROPIC FUNCTION; MECHANISMS BY WHICH NEURAL PEPTIDES MIGHT REACH THE CSF; BIOLOGIC ACTION; ENDOGENOUS NEURAL PEPTIDES IN THE CSF; SUMMARY AND CONCLUSIONS; REFERENCES
- Chapter 4. Neuropeptides in shock and traumatic injury: sites and mechanisms of actionINTRODUCTION; MULTIPLE FORMS OF ENDOGENOUS OPIOIDS AND THEIR LOCALIZATIONS; REGULATION OF ENDOGENOUS OPIOID RELEASE; MULTIPLE OPIOID RECEPTORS; ENDOGENOUS OPIOID SYSTEMS IN THE PATHOPHYSIOLOGY OF SHOCK; NEUROENDOCRINE-ENDOGENOUS OPIOID RELATIONSHIPS IN EXPERIMENTAL SHOCK; THYROTROPIN RELEASING HORMONE AS A PHYSIOLOGICAL ANTAGONIST OF OPIOID SYSTEMS; CONCLUSIONS AND PERSPECTIVES; ACKNOWLEDGMENTS; REFERENCES; Chapter 5. Ectopic hormone production by tumors: growth hormone-releasing factor
- INTRODUCTION AND HISTORICAL BACKGROUNDCLINICAL STUDIES SUGGESTING ECTOPIC PRODUCTION OF GRF; BIOLOGIC CHARACTERIZATION OF ECTOPIC GH-RELEASING FACTOR; ISOLATION AND CHARACTERIZATION OF ECTOPIC GRF; CLINICAL EFFECTS OF SYNTHETIC GRF; RADIOIMMUNOASSAY OF GRF; CLINICAL IMPLICATIONS OF ENDOGENOUS GRF; POSSIBLE ROLE OF HYPOTHALAMIC GRF IN THE ETIOLOGY OF GH-SECRETING PITUITARY TUMORS; ACKNOWLEDGMENT; REFERENCES; Chapter 6. The onset of female puberty: underlying neuroendocrine mechanisms; INTRODUCTION; THE INITIATION OF GONADOTROPIN RELEASE; THE INITIATION OF OVARIAN STEROID SECRETION
- THE NEONATAL-INFANTILE PERIODTHE JUVENILE PERIOD (CHILDHOOD); THE ONSET OF PUBERTY; THE FIRST PREOVULATORY SURGE OF GONADOTROPINS; ACKNOWLEDGMENTS; REFERENCES; Chapter 7. Prolactin and ovarian function; INTRODUCTION; PROLACTIN AND THE NORMAL OVARIAN CYCLE; PROLACTIN AND PUBERTY; LACTATION AND OVARIAN ACTIVITY; CONCLUSIONS; REFERENCES; Chapter 8. Antimitotic actions of dopaminergic drugs on human pituitary tumors; INTRODUCTION; EFFECTS ON THE SYNTHESIS AND SECRETION OF PROLACTIN; EFFECTS ON CELL DIVISION; DATA FROM EXPERIMENTAL RAT PITUITARY TUMOR STUDIES; STUDIES IN MAN; CONCLUSIONS